India has approved the use of hydroxychloroquine (HCQ) in Type 2 diabetes - potentially the first such clearance for the product.
Innovator Sanofi's Plaquenil (hydroxychloroquine sulfate) is currently indicated for the treatment of rheumatoid arthritis, lupus disease and malaria, though Plaquenil...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
